The purpose of biomarker is to measure a biological or pathogenic process so as to predict disease prognosis. Biomarkers are important because it can be used for monitoring drug safety, identifying individuals who are most likely to respond to specific treatments, stratification of presymptomatic patients and also quantification of treatment benefits. The peripheral blood based identification of biomarkers or disease signatures from psychiatric patients may possess a great potential towards drug developmental process. Identification of putative biomarkers is a need of modern society that could be used as an early diagnostic tool for neuropsychiatric disorders. Patent provides a legal protection given to a new invention which gives the holder exclusive right to use or sell the patented product. Hence, depth understanding towards patent system so as to protect the novel research outputs leading to invention of new drugs. The present review is focused on the patents on peripheral biomarkers including cerebrospinal fluid (CSF), plasma, serum and various neuropsychiatric disorders are also discussed.
Biomarker, cerebrospinal fluid (CSF), epigenetics, miRNA, neuropsychiatric disorders, patent, plasma, serum